Journals / Bezm-i Alem Valide Sultan SSK Vakıf Gureba Eğitim Hastanesi Derg. / 2005 / Cilt: 3 - Sayı: 1

Rhinoorbital mycormycosis: A case report

Rinoorbital mukormikoz: Olgu sunumu

Pages
37–40
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We describe the clinical and radio-logic presentation of this case and discuss its etiology, diag­nosis, treatment and prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Paranasal sinus mucormycosis (PSM) is an invasive, high­ly aggressive fungal infection that usually occurs in diabe­tic patients in the setting of ketoacidosis or in immunosup-pressive conditions (such as leukemia, lymphoma, kidney failure).
📊
Key Findings & Data:Prompt surgical debridement of all clinically non-viable tissue is required.
💡
Conclusion & Impact:We describe the clinical and radio-logic presentation of this case and discuss its etiology, diag­nosis, treatment and prognosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Paranasal sinus mucormycosis (PSM) is an invasive, high­ly aggressive fungal infection that usually occurs in diabe­tic patients in the setting of ketoacidosis or in immunosup-pressive conditions (such as leukemia, lymphoma, kidney failure). Prompt surgical debridement of all clinically non-viable tissue is required. Systemic antifungal therapy and management of hyperglycemia in diabetic patients are the other cornerstones of treatment. In addition, nowadays hyperbaric oxygen therapy, as an adjunct to surgical debridement and antifungal therapy, is being used. In this article we present a case of rhinoorbilal mucormycosis with diabetic ketoacidosis. We describe the clinical and radio-logic presentation of this case and discuss its etiology, diag­nosis, treatment and prognosis.

Özet

Mukormikoz; paranazal sinüslerin nadir görülen, ancak mortalite ve morbiditesi çok yüksek olan bir enfeksiyöz hastalığıdır. Sıklıkla kontrolsüz tip 2 diyabette görülen ketoasidoz. lösemi, lenfoma, kortikosteroid kullanımı ve kronik böbrek yetersizliği gibi durumlarda görülür. Hızlı ve geniş bir cerrahi debridmanın yanı sıra, sistemik antifungal tedavi ve mevcut diabclin kontrol altına alınması tedavide­ki en önemli noktalardır. Günümüzde bu tedavi modal itelerine ek olarak hiperbarik oksijen tedavisi de kul­lanılmaya başlanmıştır. Bu yazıda diyabetik keloasidoza bağlı olarak ortaya çıkan bir rinoorbital mukormikoz olgusunu sunarak; hastalığın kliniği, tedavisi ve prognozu ile ilgili özelliklerini gözden geçirdik.

🔖

Cite This Article

SANİSOĞLU, O., AYAN, N., GÜRSEL, A. O., TAŞ, E., EREN, Y., BİLAZER, M., ŞAHİN, E., TÜRKÖZ, M. K. (2022). Rhinoorbital mycormycosis: A case report. Bezm-i Alem Valide Sultan SSK Vakıf Gureba Eğitim Hastanesi Derg., Cilt: 3 - Sayı: 1, 37–40. https://ajindex.com/articles/464156

References (7)

  1. Kwon-Chong Kj, Bennet JE. Medical mycology. Philedelphia: Lea & Febiger, 1992.
  2. Van Johnson E, Kline LB, Julian BA, et al. Bilateral cavernousninus thrombosis due. to mucurmycosis. Arch Ophtalmol, 1988;106:1089-92. O'hara M. Histopathologic diagnosis of fungal diseases. Infection Control 1986;7:78-84.
  3. Galeta SL, Wulc AE, Goldberg HI, et al. Rhinocerebral mucormycosis: management and survival after carotid occlusion. Ann Neurol 1990;28:103-7. Finn DG. Mucormycosis of the paranazal sinuses. Ear. Nose Throat J 1988;67:813-22.
  4. Yohai RA, Bullock JD, Aziz AA et al. Survival factors in rhinoorbital-cerebral mucormycosis. Surv Ophtalmol 1994;39:3-22.
  5. Lansford BK, Bower CM, Seibert RW. Invasive fungal sinusitis in the irnmunocompromised pediatric patient. Ear Nose Throat J 1995;8:566-73.
  6. Pillsbury HC, Fischer ND. Rhinocerebral mucormycosis. Arch Otolaryngol 1977;103:600-4.
  7. Vessely MB, Zitch RP III, Estrem S A,et al. Atypical presentations of mucormycosis in the head and neck. Otolaryngol. Head Neck Surg. 1996;115:573-7.